Cargando…

Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns

BACKGROUND: Personalized medicine should be encouraged because patients are complex, and this complexity results from biological, medical (eg, demographics, genetics, polypharmacy, and multimorbidities), socioeconomic, and cultural factors. Levofloxacin (LVX) is a broad-spectrum fluoroquinolone anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Chu-Han, Yu, Lu-Shan, Zeng, Su, Huang, Yu-Wen, Zhou, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972025/ https://www.ncbi.nlm.nih.gov/pubmed/24707182 http://dx.doi.org/10.2147/TCRM.S59079

Ejemplares similares

Urine Colorimetry for Levofloxacin Pharmacokinetics and Personalized Dosing in People with Drug-resistant Tuberculosis
por: Rao, Prakruti, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization
por: Cao, G, et al.
Publicado: (2013)

The Formation of β-Cyclodextrin Complexes with Levofloxacin and Ceftriaxone as an Approach to the Regulation of Drugs’ Pharmacokinetic
por: Yakupova, L. R., et al.
Publicado: (2023)

Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients
por: Setiawan, Eko, et al.
Publicado: (2022)

Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management
por: Li, Wei, et al.
Publicado: (2013)

Comparative Pharmacokinetics of Levofloxacin in Healthy Volunteers and in Patients Suffering from Typhoid Fever
por: Usman, Muhammad, et al.
Publicado: (2013)

Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
por: Wada, Takeshi, et al.
Publicado: (2015)

Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint Infections
por: Eloy, Gauthier, et al.
Publicado: (2020)

Effect of food thickener and jelly wafer on the pharmacokinetics of levofloxacin orally disintegrating tablets
por: Tomita, Takashi, et al.
Publicado: (2019)

Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
por: Sakai, Tatsuya, et al.
Publicado: (2019)

Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children
por: van der Laan, Louvina E, et al.
Publicado: (2023)

Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)
por: Sitovs, Andrejs, et al.
Publicado: (2020)

Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
por: Zhou, Yi-Ting, et al.
Publicado: (2013)

Emergence of meropenem and levofloxacin resistance in Burkholderia pseudomallei in Taiwan
por: Wu, Pin-Han, et al.
Publicado: (2023)

Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration
por: Aboubakr, Mohamed, et al.
Publicado: (2014)

1425. Population Pharmacokinetic Analysis of Ciprofloxacin and Levofloxacin in Critically Ill Trauma, Surgical, and Burn Patients
por: Ivins-O’Keefe, Kelly, et al.
Publicado: (2018)

Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
por: Sidamo, Temesgen, et al.
Publicado: (2022)

Erratum to “Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration”
por: Aboubakr, Mohamed, et al.
Publicado: (2014)

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy
por: Wang, Zhi-Yu, et al.
Publicado: (2015)

Levofloxacin-induced acute psychosis
por: Moorthy, Nagaraja, et al.
Publicado: (2008)

Acute Delirium Associated With Levofloxacin
por: Kogan, Yana, et al.
Publicado: (2018)

Levofloxacin-Induced Myoclonus and Encephalopathy
por: Reddy, V. Abhinay S. K., et al.
Publicado: (2020)

Levofloxacin-Induced Acute Pancreatitis
por: Neto Gonçalves, Tiago, et al.
Publicado: (2021)

Hepatotoxicity Secondary to Levofloxacin Use
por: Panahi, Ladan, et al.
Publicado: (2021)

Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid
por: Nishikubo, Masashi, et al.
Publicado: (2019)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

Multiple drug transporters contribute to the brain transfer of levofloxacin
por: Cen, Yuying, et al.
Publicado: (2022)

Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
por: Li, Xiao-lin, et al.
Publicado: (2022)

Levofloxacin-Resistant Haemophilus influenzae, Taiwan, 2004–2010
por: Kuo, Shu-Chen, et al.
Publicado: (2014)

Pharmacokinetics, urinary excretion and dosage regimen of levofloxacin following a single intramuscular administration in cross bred calves
por: Dumka, Vinod K., et al.
Publicado: (2006)

Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
por: Bucci, Frank A, et al.
Publicado: (2016)

Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
por: Seeger, Johanna, et al.
Publicado: (2021)

Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns
por: Khan, Johra, et al.
Publicado: (2021)

Therapeutic Drug Monitoring and Individualized Medicine of Dasatinib: Focus on Clinical Pharmacokinetics and Pharmacodynamics
por: He, Shiyu, et al.
Publicado: (2021)

Autoimmune Hemolytic Anemia Induced by Levofloxacin
por: Sheikh-Taha, Marwan, et al.
Publicado: (2014)

Clinical Factors Associated with Acquisition of Resistance to Levofloxacin in Stenotrophomonas maltophilia
por: Baek, Ji Hyeon, et al.
Publicado: (2014)

Zosteriform Fixed Drug Eruption to Levofloxacin
por: Vetrichevvel, T P, et al.
Publicado: (2012)

Levofloxacin-induced acute anxiety and insomnia
por: Kandasamy, Arun, et al.
Publicado: (2012)

Reversible craniocervical dystonia associated with levofloxacin
por: Lizarraga, Karlo J, et al.
Publicado: (2015)

A Case of Levofloxacin-Induced Hepatotoxicity
por: Schloss, Michael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o1orr8r7e9bjroi0ld9ephen5m